New framework defines core competencies for contemporary brain brachytherapy
The framework emphasizes multidisciplinary selection, source geometry, imaging, postimplant dosimetry, QA and radiation safety for modern intracranial Cs-131 brachytherapy.
The framework emphasizes multidisciplinary selection, source geometry, imaging, postimplant dosimetry, QA and radiation safety for modern intracranial Cs-131 brachytherapy.
ATG7 inhibition plus radiation doubled median survival versus untreated mice and produced long-term tumor-free survival in 40%.
Definitive interstitial or hybrid brachytherapy controlled 94% of difficult BCC/SCC lesions, although 8% developed grade 3–4 late toxicity.
Low-cost acrylic and beeswax thorax phantoms produced dose measurements comparable with a commercial phantom and generally remained within IAEA tolerance.
Upright gantry-less RT could reduce system complexity and improve access, but imaging, immobilization and limited clinical evidence remain major barriers.
In 331 Danish NPC patients, five-year failure rates were similar by EBV status, while distant relapse was concentrated in locally advanced disease.
Among 34 postoperative oral cavity cases, local failures occurred at or near the flap-native interface, with no recurrence inside the flap.
AYA patients face distinct radiation-related late effects and psychosocial challenges, yet age-specific dose constraints and prospective outcome data remain scarce.
Across 5,509 evaluable patients, 34% developed late chest-wall pain, although definitions and reported risk factors varied substantially.
Four quality-improvement measures reduced >3-mm chest-wall errors from 21.2% to 4.7%, but sternal marker placement increased skin reactions.
Interplay-related underdosage largely disappeared after five fractions, although two high-motion plans retained clinically relevant target deficits.
Distal targeting produced more overall pain relief, while proximal targeting yielded more complete pain freedom and medication discontinuation.
Bladder diameter >10 cm at simulation was associated with longer fractions, more interruptions and greater patient frustration during prostate RT.
Patients aged ≥70 reported similar or lower symptom burden, whereas PS ≥2 consistently predicted worse toxicity and slower recovery after radical RT.
Across 14 studies, 9 of 11 anxiety studies and 3 of 5 pain studies reported significant improvement with virtual reality.